Magenta Therapeutics, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by. And welcome to the Magenta Therapeutics Business Update Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Manisha Pai, Vice President, Investor Relations and Communications, Magenta Therapeutics. Thank you. Please go ahead.
Thank you, operator. And good morning, everyone. Thank you for joining us today on our conference call. Today, we will be discussing recent business updates, including yesterday's announcement of a research and clinical collaboration with AVROBIO. We issued a press release earlier this morning with our quarterly results, and that press release can be found on the Investors & Media section of our website, along with yesterday's collaboration press release.
With me on the call today with prepared remarks are Dr. Jason Gardner, Magenta's President and CEO; Dr. John Davis, our Head of R&D and Chief Medical Officer; and Dr. Rob Negrin,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |